What is the 13F Pro Quality Score for SOLS?

13F Pro ranks Solstice Advanced Materials Inc. (SOLS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SOLS's current score at https://13fpro.ai/company/SOLS (free sign-up required for the full ranking).

Where does 13F Pro source SOLS data?

All Solstice Advanced Materials Inc. fundamentals and ownership data come directly from SEC EDGAR. Solstice Advanced Materials Inc. files with the SEC under CIK 2064953. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SOLS in?

Solstice Advanced Materials Inc. (SOLS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives SOLS's revenue?

Per Solstice Advanced Materials Inc.'s latest 10-Q filed with the SEC on 2026-07-30, the biggest revenue drivers are: Refrigerants & Applied Solutions ($850M, +13% YoY); Electronic & Specialty Materials ($298M, +8% YoY); Refrigerants ($473M, +13% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/SOLS.

How often is SOLS research updated on 13F Pro?

SOLS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Solstice Advanced Materials Inc.(SOLS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 2064953 SOLS stock profile & AI dashboard →

13F Pro Quality Score

61.6/100

Rank #764 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

54.6/100

Profitability

49.9/100

Balance Sheet

62.7/100

Earnings Quality

89.5/100

Free Cash Flow

41.5/100

Institutional Flow

71.9/100

Revenue Scale

75.1/100

Dilution Risk

67.4/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why SOLS Scores 62/100

exact factor attribution · 2026-09-11

SOLS's composite is driven by earnings quality and scale, held back by free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+4.0 pts

90th pct

Scale

+3.8 pts

75th pct

Capital efficiency

+1.3 pts

63th pct

Institutional flow

+1.1 pts

72th pct

Earnings growth

+1.0 pts

70th pct

Revenue growth

+0.9 pts

55th pct

Shareholder dilution

+0.9 pts

67th pct

Profitability

-0.0 pts

50th pct

Free cash flow

-1.3 pts

42th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

SOLS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Solstice Advanced Materials Inc. (SOLS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SOLS at 61.6/100 on a 32-signal composite quality model, placing it at rank #764 of 2,961 stocks — the top half of the AI-ranked universe. SOLS scores in the top quartile across earnings quality (89.5), revenue scale (75.1). Based on the latest XBRL financial filings (Q2 2026), Solstice Advanced Materials Inc. reports quarterly revenue of $1.1B, net income of $119.0M, an operating margin of 15.3%. Top institutional holders of SOLS by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. SOLS trades on the Nasdaq exchange and files with the SEC under CIK 2064953. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SOLS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Solstice Advanced Materials Inc. directly from SEC EDGAR. Solstice Advanced Materials Inc.'s 13F Pro composite quality score has ranged between 45 and 64 since 2026, currently 61.6 — a stable long-term trajectory across 19 quarterly and live scoring snapshots.

What's Driving SOLS's Business? Latest 10-Q Breakdown

✓ 30/30 datapoints verified

AI-extracted from Solstice Advanced Materials Inc.'s 10-Q filed 2026-07-30 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Solstice grew net sales 11% YoY to $1,148M on broad-based volume and pricing gains, but operating leverage weakened as interest expense from post-spin-off debt surged to $23M from $2M and RAS segment margins compressed.

Biggest Revenue Drivers

Refrigerants & Applied Solutions$850M+13% YoY

Volume growth from the ongoing transition to LGWP refrigerants and higher nuclear volumes, plus favorable pricing in the stationary end market

Electronic & Specialty Materials$298M+8% YoY

Volume growth in electronic materials tied to stronger memory demand in the semiconductor end market

Biggest Revenue Drivers

Total revenue: $1,148M+11% YoY

Refrigerants & Applied Solutions$850M+13% YoY

Volume growth from the ongoing transition to LGWP refrigerants and higher nuclear volumes, plus favorable pricing in the stationary end market

Within Refrigerants & Applied Solutions

Refrigerants$473M+13% YoY

Nuclear$125M+28% YoY

Volume increases in conversion services

Electronic & Specialty Materials$298M+8% YoY

Volume growth in electronic materials tied to stronger memory demand in the semiconductor end market

Within Electronic & Specialty Materials

Electronic Materials$119M+14% YoY

Largest Expense Items

Total cost of products and services sold$778M+16% YoY

Volume increases and inflation in raw materials, primarily in the RAS segment

Selling, general and administrative expenses$123M+17% YoY

Increase in employee-related expenses from additional headcount needed to operate as an independent public company

Interest and other financial charges$23MNM YoY (from $2M)

Debt issued in connection with the Spin-off in the second half of 2025

Research and development expenses$25M+11% YoY

Continued investment in innovation, including Spectra Y and next-generation molecules

Margins: Gross margin fell to 32% of net sales from 35% as cost of products and services sold (+16%) outpaced revenue growth on volume increases and raw material inflation. RAS segment Adjusted EBITDA margin dropped to 32.9% from 39.4% on plant turnaround timing and the absence of prior-year production incentive credits, while ESM margin improved to 21.6% from 18.8%.

Watch Items from the Filing

Subsequent to quarter-end, Solstice agreed to acquire Element Solutions in a cash-and-stock deal financed by a $4.685B bridge facility; pro forma combined debt would be approximately $7B, and termination could trigger fees up to $513M.
Interest and other financial charges rose to $23M from $2M YoY, reflecting debt issued alongside the October 2025 spin-off from Honeywell, ahead of even larger anticipated Element Solutions deal financing.
RAS segment Adjusted EBITDA margin declined 6 points YoY to 32.9%, driven by the timing of plant turnaround activity and the absence of prior-year production incentive credits.
Ongoing Nuclear Facility litigation includes a pending class action (certification ruling expected 2026), a personal injury case, and city/county contamination claims awaiting summary judgment rulings in 2026.
Related-party transactions remain material, including $29M of quarterly product sales to affiliates and a consolidated ConverDyn VIE with $73M in accrued liabilities owed to a General Atomics affiliate.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$1.1B

Net Income

Q2 2026

$119.0M

Free Cash Flow

Q2 2026

$124.0M

Operating Margin

Q2 2026

15.3%

ROIC

Q2 2026

19.2%

D/E Ratio

Q2 2026

1.32

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+3.1% YoY

$3.89BFY 2025

FY22 —FY23 $3.65BFY24 $3.77BFY25 $3.89B

Net Income

-60.1% YoY

$237.0MFY 2025

FY22 —FY23 $621.0MFY24 $594.0MFY25 $237.0M

EPS (Diluted)

-60.2% YoY

$1.49FY 2025

FY22 —FY23 $3.91FY24 $3.74FY25 $1.49

Total Assets

+13.4% YoY

$5.67BFY 2025

FY22 —FY23 —FY24 $5.00BFY25 $5.67B

Total Debt

+3449.2% YoY

$2.09BFY 2025

FY22 —FY23 —FY24 $59.0MFY25 $2.09B

Op. Cash Flow

-46.0% YoY

$455.0MFY 2025

FY22 —FY23 $760.0MFY24 $842.0MFY25 $455.0M

Free Cash Flow

-78.2% YoY

$119.0MFY 2025

FY22 —FY23 $461.0MFY24 $546.0MFY25 $119.0M

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Revenue	$3.89B +3.1%	$3.77B +3.3%	$3.65B	—
Net Income	$237.0M -60.1%	$594.0M -4.3%	$621.0M	—
EPS (Diluted)	$1.49 -60.2%	$3.74 -4.3%	$3.91	—
Total Assets	$5.67B +13.4%	$5.00B	—	—
Total Debt	$2.09B +3449.2%	$59.0M	—	—
Operating Cash Flow	$455.0M -46.0%	$842.0M +10.8%	$760.0M	—
Free Cash Flow	$119.0M -78.2%	$546.0M +18.4%	$461.0M	—

Get alerted when SOLS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Solstice Advanced Materials Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SOLS

BlackRock, Inc.
$1.4B15,931,864 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$703.7M7,942,655 sh
VANGUARD CAPITAL MANAGEMENT LLC
$635.6M7,173,963 sh
STATE STREET CORP
$448.6M5,063,616 sh
PRICE T ROWE ASSOCIATES INC /MD/
$313.3M3,536,625 sh
TWO SIGMA INVESTMENTS, LP
$297.3M3,355,801 sh
GEODE CAPITAL MANAGEMENT, LLC
$291.7M3,291,746 sh
GOLDMAN SACHS GROUP INC
$255.2M2,880,302 sh
MORGAN STANLEY
$250.9M2,831,377 sh
Castle Hook Partners LP
$197.3M2,226,617 sh

Fund	Value	Shares
BlackRock, Inc.	$1.4B	15,931,864
VANGUARD PORTFOLIO MANAGEMENT LLC	$703.7M	7,942,655
VANGUARD CAPITAL MANAGEMENT LLC	$635.6M	7,173,963
STATE STREET CORP	$448.6M	5,063,616
PRICE T ROWE ASSOCIATES INC /MD/	$313.3M	3,536,625
TWO SIGMA INVESTMENTS, LP	$297.3M	3,355,801
GEODE CAPITAL MANAGEMENT, LLC	$291.7M	3,291,746
GOLDMAN SACHS GROUP INC	$255.2M	2,880,302
MORGAN STANLEY	$250.9M	2,831,377
Castle Hook Partners LP	$197.3M	2,226,617

Companies Similar to SOLS

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

GEHC

GE HealthCare Technologies Inc.

AI score

Very similar · 11 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC ANCHOR CAPITAL ADVISORS LLC STOREBRAND ASSET MANAGEMENT AS

MDT

Medtronic plc

AI score

Very similar · 11 shared holders

Epoch Investment Partners, Inc.STOREBRAND ASSET MANAGEMENT AS WORLDQUANT MILLENNIUM ADVISORS LLC

ABT

ABBOTT LABORATORIES

AI score

Very similar · 16 shared holders

Holocene Advisors, LP Alyeska Investment Group, L.P.STOREBRAND ASSET MANAGEMENT AS

CVS

CVS HEALTH Corp

AI score

Very similar · 15 shared holders

Clearbridge Investments, LLC Holocene Advisors, LP Alyeska Investment Group, L.P.

DGX

QUEST DIAGNOSTICS INC

AI score

Very similar · 9 shared holders

STOREBRAND ASSET MANAGEMENT AS Ceredex Value Advisors LLC Copeland Capital Management, LLC

LABCORP HOLDINGS INC.

AI score

Very similar · 9 shared holders

DEROY & DEVEREAUX PRIVATE INVESTMENT COUNSEL INC Select Equity Group, L.P.NEEDHAM INVESTMENT MANAGEMENT LLC

MMM

3M CO

AI score

Very similar · 12 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Holocene Advisors, LP STOREBRAND ASSET MANAGEMENT AS

PFE

PFIZER INC

AI score

Very similar · 10 shared holders

Epoch Investment Partners, Inc.STOREBRAND ASSET MANAGEMENT AS Retirement Systems of Alabama

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SOLS on your watchlist

Track score changes the day Solstice Advanced Materials Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SOLS a good stock to buy?

13F Pro's AI-powered analysis of Solstice Advanced Materials Inc. (SOLS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SOLS are available on the SOLS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SOLS is classified as a mid company.

Which hedge funds own SOLS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SOLS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Solstice Advanced Materials Inc.'s investment landscape.